ctrl K

Watchlist Price Alert

Zentalis Pharmaceuticals ... (ZNTL)

NASDAQ: ZNTL · Real-Time Price · USD

1.20

-0.04 (-3.23%)

At close: May 23, 2025, 3:59 PM

1.21

0.75%

After-hours: May 23, 2025, 05:53 PM EDT

Zentalis Pharmaceuticals Revenue Breakdown

Period Ending	Dec 31, 2024
Reportable Segment Revenue	67.42M
Reportable Segment Revenue Growth	n/a

Operating Expense Breakdown

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Selling, General, and Administrative Revenue	10.58M	40.01M	14.61M	16.76M	15.42M	16.03M	15.95M	15.66M	16.37M	11.14M	12.01M	19.64M	11.77M	9.75M	8.87M	10.36M	11.95M	10.72M	10.1M	9.92M	3.14M	3.04M	1.84M	1.95M	1.63M
Selling, General, and Administrative Revenue Growth	-73.55%	+173.86%	-12.85%	+8.73%	-3.82%	+0.47%	+1.84%	-4.31%	+46.97%	-7.28%	-38.83%	+66.87%	+20.64%	+9.94%	-14.38%	-13.31%	+11.46%	+6.21%	+1.74%	+215.95%	+3.46%	+64.64%	-5.24%	+19.17%	n/a
Research and Development Revenue	27.25M	32.97M	36.82M	48.39M	49.59M	51.56M	46.77M	42.68M	48.58M	40.62M	42.18M	43.83M	46.11M	38.44M	54M	44.77M	38.39M	29.52M	24.67M	17.45M	13.26M	11.87M	10.74M	8.69M	7.09M
Research and Development Revenue Growth	-17.37%	-10.46%	-23.90%	-2.42%	-3.82%	+10.25%	+9.56%	-12.14%	+19.62%	-3.71%	-3.75%	-4.96%	+19.96%	-28.81%	+20.61%	+16.61%	+30.06%	+19.66%	+41.36%	+31.63%	+11.70%	+10.52%	+23.59%	+22.57%	n/a